Abstract
Authors’ Responses to Peer Reviews of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
Highlights
This is the authors’ response to peer-review reports for the paper “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
The “33.5, SD 11.7” value in the Results section is the average first flow rate documented in our Electronic Medical Record (EMR). 3
The first two paragraphs were written as a summary of the overall results as stated by the journal guidelines for the discussion
Summary
Authors’ Responses to Peer Reviews of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”. Maulin Patel, MD; Junad Chowdhury, MD; Nicole Mills, DO; Robert Marron, MD; Andrew Gangemi, MD; Zachariah Dorey-Stein, MD; Ibraheem Yousef, MD; Matthew Zheng, MD; Lauren Tragesser, MD; Julie Giurintano, MD; Rohit Gupta, MD; Parth Rali, MD; Gilbert D'Alonzo, DO; Huaqing Zhao, PhD; Nicole Patlakh, BSc; Nathaniel Marchetti, DO; Gerard Criner, MD; Matthew Gordon, MD. KEYWORDS respiratory; medicine; nasal therapy; COVID-19; mechanical ventilation; ventilators; mortality; morbidity; intubation. This is the authors’ response to peer-review reports for the paper “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
